adamantane has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garcia Gil, M; Sanchez Crespo, M | 1 |
| Dear, JW; Foreman, JC; Turner, PJ | 1 |
1 trial(s) available for adamantane and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Involvement of kinins in hyperresponsiveness induced by platelet activating factor in the human nasal airway.
Topics: Adamantane; Adult; Area Under Curve; Blood Proteins; Bradykinin; Bradykinin Receptor Antagonists; Eosinophil Granule Proteins; Histamine Release; Humans; Kinins; Middle Aged; Nasal Cavity; Platelet Activating Factor; Receptor, Bradykinin B2; Ribonucleases; Therapeutic Irrigation | 2000 |
1 other study(ies) available for adamantane and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Dansylcadaverine and rimantadine inhibition of phagocytosis, PAF-acether release, and phosphatidylcholine synthesis in human polymorphonuclear leukocytes.
Topics: Adamantane; Amantadine; Antineoplastic Agents; Cadaverine; Diamines; Humans; Neutrophils; Phagocytosis; Phosphatidylcholines; Platelet Activating Factor; Rimantadine | 1983 |